O'Reilly S M, Barnes D M, Camplejohn R S, Bartkova J, Gregory W M, Richards M A
ICRF Clinical Oncology Unit, Guy's Hospital, London, UK.
Br J Cancer. 1991 Mar;63(3):444-6. doi: 10.1038/bjc.1991.102.
The relationship between c-erbB-2 gene expression (assessed immunohistochemically), S-phase fraction (SPF) and prognosis has been analysed in 172 women with primary breast cancer. c-erbB-2 staining was independent of age, tumour size, number of nodes involved, tumour grade and DNA ploidy, but was more common in oestrogen receptor (ER) negative tumours (P = 0.02) and progesterone receptor (PgR) negative tumours (P = 0.03). A weak correlation between c-erbB-2 staining and SPF was observed (r = 0.18). Amongst women with node negative disease, SPF was significantly related to relapse free survival (RFS, P = 0.04) while c-erbB-2 staining was not (P = 0.2). In contrast, both SPF (P = 0.002) and c-erbB-2 staining (P = 0.016) provided significant prognostic information on RFS for women with node positive disease. Multivariate analysis showed that c-erbB-2 staining and SPF gave independent information on RFS for women with node positive disease.
对172例原发性乳腺癌女性患者分析了c-erbB-2基因表达(通过免疫组织化学评估)、S期细胞分数(SPF)与预后之间的关系。c-erbB-2染色与年龄、肿瘤大小、受累淋巴结数量、肿瘤分级及DNA倍体无关,但在雌激素受体(ER)阴性肿瘤(P = 0.02)和孕激素受体(PgR)阴性肿瘤(P = 0.03)中更常见。观察到c-erbB-2染色与SPF之间存在弱相关性(r = 0.18)。在无淋巴结转移的女性患者中,SPF与无复发生存期(RFS,P = 0.04)显著相关,而c-erbB-2染色则不然(P = 0.2)。相反,对于有淋巴结转移的女性患者,SPF(P = 0.002)和c-erbB-2染色(P = 0.016)均为RFS提供了显著的预后信息。多变量分析表明,对于有淋巴结转移的女性患者,c-erbB-2染色和SPF为RFS提供了独立的信息。